FDA Inspection
Lotte Biologics USA, LLCLotte Biologics USA, LLC – FDA Inspection, Sep 19, 2024
Record Details
This FDA Inspection record concerns Lotte Biologics USA, LLC, with an inspection on September 19, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9aaba3dc-a2a2-4ba3-a1f6-76f467eecef0
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1246771
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Lotte Biologics USA, LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2026 | Not classified | New York District Office | |
| June 5, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 20, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lotte Biologics USA, LLC
- FDA Inspection 1341414 - 2026-09-18
- FDA Inspection 1093554 - 2019-06-05
- FDA Inspection 1010187 - 2017-04-28
- FDA Inspection 897857 - 2014-09-25
- FDA Inspection 794472 - 2012-07-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.